Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of Artificial Intelligence ECG With ECG Devices to Detect Hypertrophic Cardiomyopathy Distinct From Athlete's
Sponsor: Mayo Clinic
Summary
The purpose of this study is to evaluate the AI-ECG algorithm for HCM in detecting HCM and in differentiating it from athlete's using not only the standard 12-lead ECG, but also ECGs obtained with the Apple Watch and Alivecor KardiaMobile devices.
Official title: Prospective Evaluation of Artificial Intelligence ECG With Consumer-Facing ECG Devices for Detection of Hypertrophic Cardiomyopathy and Distinction From Athlete's
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
183
Start Date
2024-05-07
Completion Date
2026-12
Last Updated
2026-03-19
Healthy Volunteers
No
Conditions
Interventions
12-Lead ECG
A clinically performed 12-lead ECG tracing within 30 days of the appointment will be obtained from the subject medical record and will be used for AI-ECG analyses.
Apple Smart Watch Single Lead ECG
A single lead ECG tracing will be collected using an Apple Smart Watch and tracing will be used for AI-ECG analyses.
AliveCor KardiaMobile 6-Lead ECG
A 6-lead ECG tracing will be collected using an AliveCor KardiaMobile device and tracing will be used for AI-ECG analyses.
Locations (1)
Mayo Clinic in Rochester
Rochester, Minnesota, United States